Clinical Research Centersp. z o.o.
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 90 days late).
- 2025filed
- 202426/06/2025
- 202327/06/2024
- 202211/07/2023
- 202113/10/2022
- 202006/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The company may be represented by two members of the management board acting jointly or by one member of the management board jointly with a commercial proxy. If there is only one member of the management board, that member represents the company alone, regardless of the value of the obligation incurred.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bartosz Romuald Bednarekage 52 | 34 | $459.21 | 33.3333% |
Robert Fedorowiczage 52 | 34 | $459.21 | 33.3333% |
Michał Piotr Kretkowskiage 52 | 34 | $459.21 | 33.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2014-05-01.
72 1050 1520 1000 0090 9984 0549
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Biodecsp. z o.o. | $115,508.63 | biodec.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
Last updated: 2026-04-24